Basic Information
AlgoTx is a European biotechnology company developing ATX01, a non-opioid drug for the localized treatment of peripheral neuropathic pain. AlgoTx creates novel solutions to alleviate "complex pain" that is difficult to treat, achieving this by prioritizing indications without proven and approved treatments and tailoring therapies to meet the highly specific needs of affected patients.
AlgoTherapeutix SAS
Ile-de-France,France
less than 15 people
January 01, 2018
contact@algotx.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios